Le Lézard
Classified in: Health
Subject: PER

Lisa Genova, Ph.D joins CereVasc Board of Directors


BOSTON, Jan. 16, 2019 /PRNewswire/ -- CereVasc, LLC, a company focused on improving the care of patients with communicating hydrocephalus announced today the addition of acclaimed neuroscientist and author Lisa Genova, Ph.D., to the Board of Directors. 

Dr. Genova is the New York Times bestselling author of several novels inspired by neuroscience and the human spirit. Her works include Still Alice, which was adapted into an Oscar winning film by the same name, Left Neglected, Love Anthony, Inside the O'Briens, and Every Note Played.

"We are delighted to have Lisa join our team. Lisa's graduate training in neuroscience combined with her expertise and knowledge of neurodegenerative disease will be very valuable to CereVasc as we continue to pursue evidence to support use of our technology in treating dementia associated with normal pressure hydrocephalus, future application of our technology in delivery of therapeutic agents directly to the central nervous system, and further evaluate the use of our approach in treating other neurodegenerative diseases," said Dan Levangie, Chairman & CEO of CereVasc, LLC.

"CereVasc's vision for cerebrospinal fluid management is unique, innovative, and important for patients," said Dr. Genova. "I look forward to working with CereVasc in advancing their technology as we strive to treat a variety of brain disorders."

Dr. Genova graduated valedictorian from Bates College with a degree in biopsychology and holds a Ph.D. in neuroscience from Harvard University. She travels worldwide speaking about the neurological diseases she writes about and has appeared on The Dr. Oz Show, TodayPBS NewsHour, CNN, and NPR. Her TED talk, What You Can Do To Prevent Alzheimer's, has been viewed more than 3.5 million times.

Lisa was named one of the U.S. Top 50 Influencers in Aging by Next Avenue. She received The Pell Center Prize for Story in the Public Square, for "distinguished storytelling that has enriched the public dialogue," The Sargent and Eunice Shriver Profiles in Dignity Award, the National Alzheimer's Association's Rita Hayworth Award, The Global Genes RARE Champions of Hope Award, and The American College of Neuropsychopharmacology Media Award for "informing the public about Treatment and ongoing research in medical illness."

About CereVasc, LLC
CereVasc, LLC is a medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases. The Company's first product, the eShunttm System, is an endovascularly deliverable cerebrospinal fluid shunt and associated delivery componentry designed to avoid the need for invasive surgery, general anesthesia and hospitalization associated with the current surgical treatment of communicating hydrocephalus using ventriculo-peritoneal shunts.

SOURCE CereVasc, LLC


These press releases may also interest you

at 13:02
All resolutions were approved by 100% of the participating Noteholders and C Warrantholders Noteholders representing 99.9% of total outstanding principal amount participatedNovasep Holding S.A.S ("Novasep"), a leading supplier of services and...

at 13:02
The leadership team of Watercrest Senior Living Group and Titan Development Real Estate Fund I are pleased to announce that construction is more than 65% complete at Watercrest Columbia Assisted Living and Memory Care in Columbia, SC. The 107-unit,...

at 12:53
The majority of people struggling with addiction to drugs and alcohol in this country have faced some kind of traumatic experience. Trauma results from an event, series of events, or set of circumstances experienced by an individual as physically or...

at 12:35
Canada's largest and longest-running health and safety conference and trade show, Partners in Prevention 2019, takes place on April 30 and May 1, 2019 in Toronto. This year's edition, with the theme What's Your Story?, will highlight the 'safety...

at 12:33
The American Academy of Forensic Sciences (AAFS) presented Yale H. Caplan, PhD, with the prestigious Gradwohl Medallion today as a Gradwohl Laureate, during the Academy's 71st Annual Scientific Meeting in Baltimore, MD. Caplan joins an elite group of...

at 12:30
Clostridioides difficile (C.diff) is a serious and highly contagious intestinal infection that can cause diarrhea, colitis and even death. Even with the world's most robust infection prevention strategy and protocols, the Mayo...



News published on 16 january 2019 at 08:00 and distributed by: